---
title: InsightRX Announces the Release of InsightRX GEMINI Model-selection Algorithm
description: InsightRX introduces GEMINI Model-selection Algorithm, automating vancomycin dosing model selection to enhance precision and save clinician time.
image: https://blog.insight-rx.com/hubfs/AI-Generated%20Media/Images/pharmacokinetic%20model%20algorithm%20with%20a%20small%20gemini%20symbol%20in%20the%20image%20somewhere.jpeg
---

[![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/)

- For Providers
  
    - Solutions 
          - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd)
          - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future)
    - Products 
          - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova)
          - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo)
          - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules)
- [For Life Sciences](https://www.insight-rx.com/life-sciences)
  
    - Overview 
          - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences)
    - Products 
          - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova)
          - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra)
- Platform
  
    - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning)
    - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations)
    - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory)
    - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support)
- Resources
  
    - Science 
          - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science)
          - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications)
          - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova)
    - Explore 
          - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories)
          - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers)
          - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software)
    - [Blog](https://blog.insight-rx.com/resources) 
          - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources)
          - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation)
          - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership)
- Company
  
    - About 
          - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about)
          - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership)
          - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board)
          - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers)
          - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers)
    - Press 
          - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases)
          - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases)
          - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media)

[![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574)

[![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574)

Press Releases

# InsightRX Announces the Release of InsightRX GEMINI Model-selection Algorithm

- Published  August 27, 2024

By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx)

![](https://blog.insight-rx.com/hubfs/AI-Generated%20Media/Images/pharmacokinetic%20model%20algorithm%20with%20a%20small%20gemini%20symbol%20in%20the%20image%20somewhere.jpeg)

InsightRX GEMINI℠ is designed to save clinician time and eliminate the need for manual model filtering

**SAN FRANCISCO, Aug. 27, 2024** — [InsightRX](https://www.insight-rx.com/) – the leader in Bayesian model-informed precision dosing software – today announced the release of InsightRX GEMINI℠. Officially released to customers on July 30, 2024, this enhanced dose-selection algorithm for vancomycin was built from datasets of more than 384,000 treatment courses.

Clinical guidelines recommend dosing vancomycin based on area under the plasma drug concentration-time curve (AUC). Just as a one-dose-fits all strategy doesn’t balance therapeutic efficacy with drug toxicity, there is growing evidence that different patient populations are best described using different models. For model-informed dose selection, the model used needs to be sufficiently predictive, however reviewing the literature to assess which model best suits a patient is a time-consuming process.

In just one-click, InsightRX GEMINI℠ works by:

1. Parsing out relevant patient data based on vancomycin’s pharmacokinetics (PK)
2. Making an initial PK model selection from InsightRX’s validated catalog
3. Accessing InsightRX’s real-world data network to match the treatment patient to similar historical patients to compare PK model performance
4. Summarizing and reviewing learnings to objectively select the best performing PK model to determine dosing

The new algorithm is based on experience and research, following seven years of applying model-informed precision dosing (MIPD) to treat over one million patients. InsightRX GEMINI℠ automates the selection of the most effective vancomycin PK model at the start of therapy, using patient characteristics known to impact model performance, like body mass index (BMI) and age. Auto-selected models can reduce bias, and result in better overall performance – ensuring a consistent best-practice standardization across healthcare systems.

External validation of the algorithm in a separate dataset of 144,000 patients showed that following the InsightRX GEMINI℠ model selection increased model prediction accuracy by as much as 47% from baseline compared to a single-model approach.

InsightRX developed an algorithm to select the best model for for a given patient based on the model’s historic performance in similar patients, evaluating models in 130+ patient characteristic combinations. This innovative algorithm is born from the collaborative power of InsightRX’s seasoned data scientists and clinical pharmacy specialists, following in the footsteps of InsightRX’s recent release of the [first commercially available precision dosing model for heparin on the market](https://blog.insight-rx.com/press-releases/northern-arizona-healthcare-insightrx-precision-dosing-model-heparin).

“Clinicians have been asking for a one-click application to select the best model to determine vancomycin dosing,”  said Sirj Goswami, Ph.D., InsightRX CEO and co-founder. “InsightRX GEMINI℠ removes the manual patient-factor selection process, making the intervention process faster at the point of care.”

Learn more about InsightRX GEMINI℠ at [ASHP Midyear](https://midyear.ashp.org/) (Dec 8-12 in New Orleans, LA), where the InsightRX team will be showcasing their newest products and features helping to enhance the impact of precision dosing. 

---

**About InsightRX**

InsightRX is a healthcare technology company providing a cloud-based clinical decision support platform that applies quantitative pharmacology and AI to enhance therapeutic decision-making from phase I drug development to point of care. The company’s platform provides an individualized, predictive understanding of a patient’s response to treatment which enables an enhanced understanding of dose-effect response and toxicity for clinicians to improve medication effectiveness.

[vancomycin](https://blog.insight-rx.com/press-releases/tag/vancomycin) [AI](https://blog.insight-rx.com/press-releases/tag/ai) [insightrx gemini](https://blog.insight-rx.com/press-releases/tag/insightrx-gemini)

#### On this page…

**Connect with us to get the latest blog updates, instantly sent to your inbox**

<https://www.linkedin.com/company/insightrx> <https://twitter.com/InsightRX> <https://www.youtube.com/@insightrx> <https://info.insight-rx.com/mailing-list-subscribe>

## Dig deeper.

Explore related articles and additional posts on the InsightRX blog.

[Press Releases Oct 19, 2022 InsightRX to Showcase New Advances in Precision Dosing Technology during IDWeek 2022](https://blog.insight-rx.com/press-releases/insightrx-showcase-new-advances-precision-dosing-technologybrat-idweek-2022) [Press Releases Nov 28, 2023 InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference](https://blog.insight-rx.com/press-releases/insightrx-brings-groundbreaking-advancements-model-informed-precision-dosing-ashp-midyear-conference) [Press Releases Mar 13, 2019 InsightRX And Children's Hospital Los Angeles (CHLA) To Partner On Precision Dosing](https://blog.insight-rx.com/press-releases/chla-bestdose-partners-precision-dosing)

#### What We Do

##### For Providers

- [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova)
- [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo)
- [Drug Modules](https://www.insight-rx.com/provider/drug-modules)

##### For Life Sciences

- [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova)
- [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra)
- [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications)

#### How We Do It

##### Platform

- [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning)
- [Integrations](https://www.insight-rx.com/platform/integrations)
- [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory)
- [Success & Support](https://www.insight-rx.com/platform/success-support)

##### Science

- [Data Science](https://www.insight-rx.com/data-science)
- [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications)

#### Information

##### Resources

- [Success Stories](https://www.insight-rx.com/success-stories)
- [White Papers](https://www.insight-rx.com/white-papers)
- [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software)
- [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova)

##### Blog

- [All Posts](https://blog.insight-rx.com/resources)
- [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation)
- [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership)

#### About

- [Our Story](https://www.insight-rx.com/about)
- [Leadership](https://www.insight-rx.com/leadership)
- [Advisory Board](https://www.insight-rx.com/advisory-board)
- [Our Customers](https://www.insight-rx.com/customers)
- [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases)
- [Media](https://blog.insight-rx.com/press-releases?section=media)
- [Careers](https://www.insight-rx.com/careers)
- [Contact](https://www.insight-rx.com/contact-us)

---

![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg)

 InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1.

 InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance.

740-05000-REC-01 · 08/2025

---

[![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/)

 548 Market Street  
 #88083  
 San Francisco, CA 94104

<https://www.linkedin.com/company/insightrx/> <https://twitter.com/InsightRX> <https://www.youtube.com/@insightrx> <https://info.insight-rx.com/mailing-list-subscribe>

---

© 2026 InsightRX, Inc. All rights reserved.

[Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "InsightRX Communications",
    "url" : "https://blog.insight-rx.com/press-releases/author/insightrx"
  },
  "dateModified" : "2025-12-14T23:55:58.695Z",
  "datePublished" : "2024-08-27T13:36:00.000Z",
  "headline" : "InsightRX Announces the Release of InsightRX GEMINI Model-selection Algorithm",
  "image" : [ "https://blog.insight-rx.com/hubfs/AI-Generated%20Media/Images/pharmacokinetic%20model%20algorithm%20with%20a%20small%20gemini%20symbol%20in%20the%20image%20somewhere.jpeg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.insight-rx.com/press-releases/insightrx-gemini-model-selection-algorithm-release",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png"
    },
    "name" : "InsightRX"
  }
}
```